Detalles de la búsqueda
1.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320176
2.
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive post-remission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385304
3.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654660
4.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer
; 129(7): 1126-1133, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37542108
5.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678031
6.
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
Ann Hematol
; 102(2): 349-358, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36564535
7.
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Blood
; 136(7): 823-830, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32496541
8.
The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial.
Haematologica
; 105(6): 1552-1558, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31467130
9.
Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donors.
Ann Hematol
; 99(12): 2723-2729, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32935189
10.
Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemia.
Ann Hematol
; 99(9): 2173-2180, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32621177
11.
An aggressive mediastinal EBV-associated large B cell lymphoma.
Histopathology
; 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38566333
12.
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.
Biol Blood Marrow Transplant
; 23(9): 1491-1497, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28527985
13.
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.
Biol Blood Marrow Transplant
; 22(3): 462-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26551637
14.
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.
Blood
; 124(26): 3870-9, 2014 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25359988
15.
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Lancet Oncol
; 16(16): 1691-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26549589
16.
The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.
Blood
; 122(1): 83-92, 2013 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23656730
17.
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 105(5): e228-e231, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31413097
18.
Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas.
Oncology
; 89(5): 294-303, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26315108
19.
Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial.
Ann Hematol
; 94(4): 557-63, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25366167
20.
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.
Blood
; 120(10): 2032-41, 2012 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-22493293